IP Library › Assignment 064357/0295
Patent Assignment
Reel/Frame 064357/0295

Change of Name

Recorded: 2023-07-24 Pages: 5
Assignor
CLEAVE BIOSCIENCES, INC.
Executed: 2019-07-15
Assignee
CLEAVE THERAPEUTICS, INC.
92 S PARK ST., SAN FRANCISCO, CALIFORNIA, 94107
Covered Property (1)
Fused Pyrimidines and Substituted Quinazolines as Inhibitors of P97
Patent: 9,062,026 →
Application: 13/946,795 →
Publication: US 2014/0024661
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 28, 2013
From: ZHOU, HAN-JIE; PARLATI, FRANCESCO
To: CLEAVE BIOSCIENCES, INC.
Reel/Frame 031490/0187 →
Assignment of Assignor's Interest Jan 22, 2015
From: ZHOU, HAN-JIE; PARLATI, FRANCESCO; WUSTROW, DAVID
To: CLEAVE BIOSCIENCES, INC.
Reel/Frame 034789/0921 →
Assignment of Assignor's Interest Jun 29, 2023
From: CLEAVE THERAPEUTICS, INC.
To: EIKON THERAPEUTICS, INC.
Reel/Frame 064118/0401 →